title: The challenges of psychopharmacological management of children with severe developmental disabilities.
authors.affiliation: Mount Sinai School of Medicine, New York, New York, USA.
authors.forename: Iliyan
authors.initials: I
authors.lastname: Ivanov
authors.forename: Martha
authors.initials: M
authors.lastname: Klein
authors.forename: Wayne Hugo
authors.initials: WH
authors.lastname: Green
authors.forename: Barbara
authors.initials: B
authors.lastname: Coffey
mesh_terms: D000927:Anticonvulsants / Q000008:administration & dosage / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001321:Autistic Disorder / Q000150:complications / Q000188:drug therapy; D017028:Caregivers; D002648:Child; D002658:Developmental Disabilities / Q000188:drug therapy*; D004827:Epilepsy / Q000150:complications / Q000188:drug therapy; D005260:Female; D005581:Foster Home Care; D005632:Fructose / Q000031:analogs & derivatives / Q000627:therapeutic use; D006801:Humans; D007175:Impulsive Behavior / Q000188:drug therapy; D008609:Mental Status Schedule; D011581:Psychological Tests; D018967:Risperidone / Q000627:therapeutic use; D013226:Status Epilepticus / Q000188:drug therapy; D000077236:Topiramate; D014635:Valproic Acid / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000927:Anticonvulsants; D014150:Antipsychotic Agents; D000077236:Topiramate; D005632:Fructose; D014635:Valproic Acid; D018967:Risperidone